Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group International will go public soon. The estimated IPO date is January 24, 2025.

IPO Price

$17.25

Shares Offered

7,325,000

Deal Size

$126.36M

AAPG Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	903.03	221.98	209.71
Revenue Growth (YoY)	-	5.85%	-
Cost of Revenue	-	30.54	22
Gross Profit	875.58	191.44	187.71
Selling, General & Admin	-	376.46	328.02
Research & Development	-	706.97	743.1
Other Operating Expenses	0	40.87	3.77
Operating Expenses	-	1,124	1,075
Operating Income	-370.36	-932.86	-887.17
Interest Expense / Income	-	96.06	52.79
Other Expense / Income	-9.83	-96.06	-52.79
Pretax Income	-360.29	-932.79	-887.17
Income Tax	-	-7.15	-4.25
Net Income	-360.54	-925.71	-882.92
Net Income Common	-360.29	-925.64	-882.92
Free Cash Flow	-750.59	-782.92	-890.88
Gross Margin	96.96%	86.24%	89.51%
Operating Margin	-41.01%	-420.24%	-423.05%
Profit Margin	-39.90%	-416.98%	-421.02%
Free Cash Flow Margin	-83.12%	-352.69%	-424.81%
EBITDA	-	-743.61	-771.47
EBITDA Margin	-	-334.98%	-367.87%
Depreciation & Amortization	-	93.2	62.92
EBIT	-	-836.81	-834.39
EBIT Margin	-	-376.97%	-397.87%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).